To understand whether BARD1ω1isoform expression contributes to AML maintenance, we performed transfection experiments with specific BARD1 siRNAs, followed by administration of 5 μM Vorinostat for 24 hours. This evidence concerns the gene BARD1 and acute myeloid leukemia.